Multiple sclerosis: A paradigm change with oral agents?; Focus On Telaprevir: A novel, protease inhibitor for the treatment of hepatitis C virus
FDA Issues Complete Response Letter for Pz-Cel to Treat Epidermolysis Bullosa
April 22nd 2024Prademagene zamikeracel is a cell therapy designed to incorporate the functional collagen-producing COL7A1 gene into a patient’s own skin cells. The FDA is asking for additional information on manufacturing practices.